Oncology Protocols Course

Lesson 1 • Cancer Staging Systems and Principles

Explains TNM staging, clinical vs. pathological staging, and stage grouping. Staging determines protocol eligibility and treatment intent.

Lesson 2 • Tumor Classification and Histopathology

Teaches histological grading, tumor origin classification, and pathology report interpretation. Connects tissue diagnosis to protocol selection.

Lesson 3 • Tumor Microenvironment and Metastasis

Describes the tumor microenvironment, angiogenesis, and metastatic cascade. Understanding spread patterns informs systemic treatment rationale.

Lesson 1 • Systemic Therapy Overview

Introduces chemotherapy, targeted therapy, immunotherapy, and hormonal therapy classes. Provides the framework for understanding protocol drug components.

Lesson 2 • Surgical Oncology Principles

Covers curative, cytoreductive, and palliative surgical goals. Establishes how surgical intent shapes multimodal protocol design.

Lesson 3 • Radiation Therapy Fundamentals

Explains ionizing radiation mechanisms, delivery techniques, and fractionation concepts. Radiation principles underpin combined-modality protocol design.

Lesson 1 • Chemotherapy Drug Classes and Mechanisms

Details alkylating agents, antimetabolites, topoisomerase inhibitors, and mitotic inhibitors. Mechanism knowledge enables accurate protocol drug identification.

Lesson 2 • Pharmacokinetics and Dose Calculation

Covers absorption, distribution, metabolism, excretion, and body surface area dosing. Accurate dose calculation is essential for protocol compliance.

Lesson 3 • Safe Handling and Hazardous Drug Protocols

Establishes standards for preparing, administering, and disposing of hazardous drugs. Protects staff and patients through strict protocol adherence.

Lesson 4 • Drug Interactions and Contraindications

Identifies clinically significant drug-drug and drug-food interactions in oncology regimens. Prevents protocol deviations caused by unrecognized interactions.

Lesson 1 • Managing Immune-Related Adverse Events

Provides graded management algorithms for immune-related toxicities across organ systems. Prompt recognition and corticosteroid use prevent severe outcomes.

Lesson 2 • Immune Checkpoint Inhibitor Protocols

Explains PD-1, PD-L1, and CTLA-4 inhibitor mechanisms and approved indications. Protocol selection depends on biomarker status and prior treatment history.

Lesson 3 • Molecular Targets and Biomarker Testing

Covers actionable mutations, gene amplifications, and companion diagnostic testing. Biomarker results directly determine targeted therapy eligibility.

Lesson 4 • Targeted Therapy Agent Classes

Details kinase inhibitors, monoclonal antibodies, and antibody-drug conjugates. Each class has distinct mechanisms, dosing schedules, and toxicity profiles.

Lesson 1 • Dosing Tables and Modification Rules

Explains how to read dosing tables, apply modification algorithms, and document changes. Dose modifications must follow protocol-specified criteria precisely.

Lesson 2 • Protocol Deviation and Violation Management

Defines protocol deviations vs. violations and required reporting steps. Proper management protects patient safety and data integrity.

Lesson 3 • Anatomy of a Clinical Protocol Document

Breaks down protocol sections including objectives, schema, eligibility, and endpoints. Familiarity with document structure accelerates accurate protocol implementation.

Lesson 4 • Response Assessment and Endpoint Evaluation

Covers response criteria frameworks, imaging schedules, and endpoint definitions. Consistent response assessment ensures valid protocol outcome data.

Lesson 1 • Nausea, Vomiting, and GI Toxicity Control

Covers emetogenic risk classification and antiemetic prophylaxis regimens. Effective GI management improves protocol adherence and quality of life.

Lesson 2 • Psychosocial and Palliative Supportive Care

Integrates psychological distress screening, palliative care referral, and advance care planning. Early palliative integration improves outcomes alongside active treatment.

Lesson 3 • Hematologic Toxicity Management

Addresses neutropenia, anemia, and thrombocytopenia management including growth factor use. Hematologic toxicity is the most common cause of protocol delays.

Lesson 4 • Nutritional Support and Metabolic Management

Covers malnutrition screening, nutritional intervention, and metabolic complication management. Nutritional status directly affects treatment tolerance and outcomes.

Lesson 1 • Site Monitoring and Audit Readiness

Prepares staff for sponsor monitoring visits, regulatory inspections, and internal audits. Audit-ready sites demonstrate consistent protocol compliance.

Lesson 2 • Regulatory and Ethical Framework

Covers informed consent requirements, ethics committee oversight, and regulatory submission standards. Compliance with ethical standards is non-negotiable in protocol conduct.

Lesson 3 • Safety Reporting and Adverse Event Management

Defines serious adverse event criteria, reporting timelines, and causality assessment. Timely safety reporting protects participants and fulfills regulatory obligations.

Lesson 4 • Clinical Trial Phases and Study Designs

Explains Phase I through IV trial objectives, endpoints, and design types. Understanding trial phases contextualizes protocol requirements and risk levels.

Lesson 1 • Patient Enrollment and Screening Workflows

Designs efficient screening logs, consent workflows, and enrollment tracking systems. Streamlined workflows maximize enrollment while maintaining eligibility accuracy.

Lesson 2 • Multidisciplinary Protocol Review Processes

Establishes tumor board integration, multidisciplinary case review, and protocol update dissemination. Team-based review reduces errors and improves protocol adherence.

Lesson 3 • Outcome Measurement and Quality Metrics

Defines key performance indicators for protocol adherence, toxicity rates, and survival endpoints. Metrics-driven review enables continuous protocol improvement.

Lesson 4 • Protocol Activation and Site Readiness

Covers feasibility assessment, staff training, and regulatory approval steps before enrollment. Thorough activation prevents early protocol deviations.